Cargando…
195. Antimicrobial Stewardship Incorporating New Antimicrobials for Use against Multi-Drug Resistant Pseudomonas aeruginosa in Cystic Fibrosis
BACKGROUND: Cystic fibrosis (CF) is a life-limiting genetic disease affecting approximately 80,000 people worldwide, including 30,000 in the United States. Chronic Pseudomonas aeruginosa (PA) infections in CF often develop to be multidrug-resistant (MDR) and are associated with worse clinical outcom...
Autores principales: | Jo, Jinhee, Gonzales-Luna, Anne J, Garey, Kevin W |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7777558/ http://dx.doi.org/10.1093/ofid/ofaa439.239 |
Ejemplares similares
-
Heterogeneous Antimicrobial Susceptibility Characteristics in Pseudomonas aeruginosa Isolates from Cystic Fibrosis Patients
por: Qin, Xuan, et al.
Publicado: (2018) -
Polymicrobial Interactions in the Cystic Fibrosis Airway Microbiome Impact the Antimicrobial Susceptibility of Pseudomonas aeruginosa
por: Reece, Emma, et al.
Publicado: (2021) -
Antimicrobial Peptides
against Multidrug-Resistant Pseudomonas aeruginosa Biofilm from Cystic Fibrosis Patients
por: Ben Hur, Daniel, et al.
Publicado: (2022) -
Antibiotic Utilization and Antimicrobial Stewardship in Community Hospitals
por: Thabit, Abrar, et al.
Publicado: (2017) -
1222. Ceftolozane-Tazobactam Heteroresistance in Cystic Fibrosis Related Pseudomonas aeruginosa Infections
por: Sanders, James, et al.
Publicado: (2021)